<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01551901</url>
  </required_header>
  <id_info>
    <org_study_id>BEN 007</org_study_id>
    <nct_id>NCT01551901</nct_id>
  </id_info>
  <brief_title>Luna Interbody System for Fusion Trial</brief_title>
  <acronym>LIFT</acronym>
  <official_title>LIFT: Luna Interbody System for Fusion Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benvenue Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Benvenue Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to evaluate the performance, safety and effectiveness of the
      Luna system for the treatment of degenerative disc disease.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of subjects with device in place showing lack of device migration or subsidence and absence of device related serious adverse event</measure>
    <time_frame>12 Month Post-op</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in pain score on the Visual Analog Scale (VAS) from baseline</measure>
    <time_frame>12 Month Post-op</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Maintenance or improvement of neurologic function related to the spine</measure>
    <time_frame>12 Month Post-op</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of subjects with lack of revision, removal, reoperation or use of additional supplemental fixation</measure>
    <time_frame>12 Month Post-op</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in Oswestry Disability Index (ODI) score from baseline</measure>
    <time_frame>12 Month Post-op</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement from baseline in quality of life as measured by SF-36</measure>
    <time_frame>12 Month Post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of device-related serious adverse events</measure>
    <time_frame>12 Month Post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of subjects with radiographic fusion of target segments</measure>
    <time_frame>12 Month Post-op</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Lower Back Pain</condition>
  <condition>Degenerative Disc Disease (DDD)</condition>
  <arm_group>
    <arm_group_label>Luna Interbody System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spinal fusion</intervention_name>
    <description>Spinal fusion procedures in skeletally mature patients with symptomatic degenerative disc disease (DDD) at one or two contiguous levels from L2-S1 with up to grade 1 spondylolisthesis</description>
    <arm_group_label>Luna Interbody System</arm_group_label>
    <other_name>Luna Interbody System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18 - 65 at the time of consent

          2. Patient has back pain consistent with symptomatic degenerative disc disease at one
             level or two contiguous levels from L2‐S1 requiring surgical intervention.

          3. Patient has had at least 6 months of non-operative care

          4. Patient is mentally capable and willing to sign a study-specific informed consent form

          5. Patient is willing and able to comply with all study requirements

          6. Patient has a score on the back pain visual analog scale (VAS) of ≥ 40 mm

          7. Patient has an Oswestry Disability Index (ODI) score of ≥ 30%

        Exclusion Criteria:

          1. DDD affecting &gt;2 levels

          2. Back pain due to causes other than DDD

          3. Spine surgery within last 3 months or planned spine surgery within 6 weeks of post
             study procedure

          4. &gt;Grade 1 spondylolisthesis or retrolisthesis

          5. Infection at or close to target disc level

          6. Active systemic infection

          7. Patient has known osteoporosis

          8. Prior interbody fusion at the target level

          9. Prior failed interbody fusion at any level

         10. Known allergy to device materials

         11. Uncontrolled psychiatric illness or severe dementia

         12. Pregnant at time of enrollment or considering getting pregnant during study period

         13. Any metabolic or other bone disease that could significantly compromise pedicle screw
             and/or interbody device placement.

         14. Any severe illness that would prevent complete study participation

         15. Uncontrolled diabetes

         16. Current use of chronic steroids (more than equivalent of 10 mg prednisone daily)

         17. Contraindication to spinal surgery or general anesthesia

         18. Coagulopathy

         19. Body mass index &gt;35

         20. Current smoker

         21. Known illicit substance abuser

         22. Currently participating in another investigational study that could affect responses
             to the study device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alphonse Lubansu, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Erasme</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinique du Parc Leopold</name>
      <address>
        <city>Bruxelles</city>
        <zip>1040</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Erasme</name>
      <address>
        <city>Bruxelles</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHC Liege</name>
      <address>
        <city>Liege</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paracelsus Kliniken</name>
      <address>
        <city>Zwickau</city>
        <zip>08008</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2012</study_first_submitted>
  <study_first_submitted_qc>March 9, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2012</study_first_posted>
  <last_update_submitted>September 18, 2014</last_update_submitted>
  <last_update_submitted_qc>September 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Back pain</keyword>
  <keyword>Spinal fusion</keyword>
  <keyword>Degenerative disc disease (DDD)</keyword>
  <keyword>Lower back pain</keyword>
  <keyword>Fusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

